Lapse and relapse following inpatient treatment of opiate dependence

Irish Medical Journal

Volumn 103, Issue 6, 2010, Pages

  Smyth, B P ^a,b   Barry, J ^b   Keenan, E ^a   Ducray, K ^c  

^a Cherry Orchard Hospital Dublin   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c Drug Treatment Centre Board   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; LOFEXIDINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; AFTERCARE; AGE; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; FAMILY THERAPY; FEMALE; FOLLOW UP; GROUP THERAPY; HEROIN DEPENDENCE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; PROSPECTIVE STUDY; PSYCHOTHERAPY; RECURRENCE RISK; RELAPSE; SURVIVAL RATE; TREATMENT OUTCOME; IRELAND; RECURRENT DISEASE; RISK FACTOR; SUBSTANCE ABUSE; SURVIVAL; UTILIZATION REVIEW;

ADOLESCENT; ADULT; AFTERCARE; AGE FACTORS; ANALGESICS, OPIOID; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERVIEWS AS TOPIC; IRELAND; MALE; METHADONE; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77954393426     PISSN: 03323102     EISSN: 03323102     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Rounsaville BJ. Clinical Implications of relapse research. In F. M. Tims & C. G. Leukefeld (Eds.), Relapse and recovery in drug abuse; 172- 184. Rockville, MD: National Institute on Drug Abuse, 1986
2. McKeganey NP. The challenge to UK drug policy. Drugs: Educ Prev and Policy 2007; 14: 559-571
3. Corrigan D, O'Gorman A. Report of the HSE Working Group on Residential Treatment & Rehabilitation (Substance Users). Dublin: Health Service Executive, 2008
4. Gossop M, Green L, Phillips G, Bradley B. Lapse, Relapse and Survival among Opiate Addicts after Treatment. A Prospective Follow-up Study. B J Psych, 1989; 154: 348-353.
5. Gossop M, Stewart D, Browne N, Marsden J. Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction 2002; 97:1259-1267.
6. Broers B, Giner F, Dumont P, Mino A. In-patient opiate detoxification in Geneva: follow-up at 1 and 6 months. Drug Alc Depend 2000; 58:85-92.
7. Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, Gossop M. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ 2003; 326,: 959-960.
8. NICE. Drug Misuse. Opioid detoxification. London: National Institute for Health & Clinical Excellence, 2007
9. Comiskey CM, Barry JA. Capture-Recapture study of the prevalence and implications of opiate use in Dublin. Eur J Pub Health 2001; 11:198-200.
10. Smyth BP, Barry J, Lane A, Cotter M, O'Neill M, Quinn C, Keenan E. Inpatient treatment of opiate dependence: Medium term follow-up outcomes. B J Psych 2005; 187, 360-365
11. Chutuape MA, Jasinski DR, Fingerhood M I, Stitzer ML. One-, Three-, and Six-Month Outcomes after brief Inpatient Opioid Detoxification. Am J Drug Alc Abuse 2001; 27:19-44.
12. Hughes J, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004; 99:29-38.
13. Chutuape MA, Silverman K, Stitzer M. Contingent reinforcement sustains post-detoxification abstinence from multiple drugs: A preliminary study with methadone patients. Drug Alc Depend 1999; 54: 69-81.
14. Center for Substance Abuse Treatment. Patient matching: Historical perspective and overview. In Matching treatment to patient needs in opioid substitution therapy: Treatment improvement protocol (TIP) 20 (DHHS Publication No. SMA 95-3049). Rockville, MD: U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, 2004.
15. Ghosde AH, Reynolds M, Baldacchino AM, Dunmore E, Byrne S, Oyefeso A, Clancy C, Crawford V. Treating an opiate-dependent inpatient population: A one-year follow-up study of treatment completers and noncompleters. Addict Behav 2002; 27:765-778.
16. Gossop M, Stewart D, Marsden J. Attendance at Narcotics Anonymous and Alcoholics Anonymous meetings, frequency of attendance and substance use outcomes after residential treatment for drug dependence: A 5-year follow-up study. Addiction 2008; 103: 119-125.
17. Sweeney B, Browne C, McKiernan B, White E. Keltoi Client Evaluation Study. Dublin: Health Service Executive, 2007.
18. Kune N, Lobmaier P, Vederhus JK, Hjerkinn B, Hegstad S, Gossop M, Kristensen Ø, Waal H. Naltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial. B J Psych 2009: 194: 541-546.
19. Langendam M, Haastrecht H, Ameijden J. The validity of drug usersâÄô self-reports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities. Int J Epid 1999; 28:514-520.
20. Donovan DM. Assessment of Addictive Behaviors for Relapse Prevention. In: Donovan DM, Marlatt GA. (Eds.), Assessment of Addictive Behaviors, Second Edition (1- 48). London: The Guilford Press, 2005.
21. Department of Health (England) and the devolved administrations. Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive, 2007.